Computational Design of a Novel Dithranol–Salicylic Acid Antipsoriatic Prodrug for Esterase-Activated Topical Drug Delivery
Psoriasis is a chronic autoimmune skin disorder characterized by the rapid overproduction of skin cells, resulting in the formation of red, inflamed, and scaly patches or plaques on the skin. Dithranol, also known as anthralin, is a very effective topical medication used in the treatment of psoriasi...
Main Authors: | Natália Andrýsková, Jozef Motyčka, Melánia Babincová, Peter Babinec, Mária Šimaljaková |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/14/3/1094 |
Similar Items
-
Electrospun PCL/PVA Coaxial Nanofibers with Embedded Titanium Dioxide and Magnetic Nanoparticles for Stabilization and Controlled Release of Dithranol for Therapy of Psoriasis
by: Natália Andrýsková, et al.
Published: (2023-07-01) -
The Effect of Szigetvár Medicinal Water on HaCaT Cells Exposed to Dithranol
by: István Szabó, et al.
Published: (2024-10-01) -
Controlled Release of Tazarotene from Magnetically Responsive Nanofiber Patch: Towards More Efficient Topical Therapy of Psoriasis
by: Natália Andrýsková, et al.
Published: (2021-11-01) -
Forget About Social Determinants when Addressing Adherence to Topical Antipsoriatic Drugs
by: Mathias Tiedemann Svendsen, et al.
Published: (2025-01-01) -
Human Skin Drug Metabolism: Relationships between Methyl Salicylate Metabolism and Esterase Activities in IVPT Skin Membranes
by: Krishna C. Telaprolu, et al.
Published: (2023-08-01)